Pharmaceutical giant AstraZeneca is set to be the next company to demand compensation from Merrill Lynch Investment Managers, for the poor performance of its pension fund in the 1990s.
The news follows the recent eight week court battle by multi-national conglomerate Unilever against MLIM, which eventually saw the two settle out of court for a reputed £70m.
Supermarket giant Sainsburys is another firm which has said it is considering suing MLIM.
Comments